Inventor · disambiguated record
John W. Facemire
Also filed as: FACEMIRE JOHN W · FACEMIRE JOHN WESTON
9 granted patents·6 pending applications·89 citations·filing 2003–2015
89Inventor score
Top patents by PatentIndex Score
15 records- 0193US8957113B2Tranexamic acid formulationsMOORE KEITH A·Filed 2011·Granted Feb 17, 2015·11 cites·30 claims
- 0292US8022106B2Tranexamic acid formulationsFERRING BV·Filed 2009·Granted Sep 20, 2011·12 cites·57 claims
- 0391US8487005B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Jul 16, 2013·12 cites·41 claims
- 0491US8273795B2Tranexamic acid formulationsMOORE KEITH A·Filed 2008·Granted Sep 25, 2012·14 cites·12 claims
- 0590US7947739B2Tranexamic acid formulationsFERRING BV·Filed 2010·Granted May 24, 2011·14 cites·19 claims
- 0688US8809394B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Aug 19, 2014·9 cites·41 claims
- 0788US8791160B2Tranexamic acid formulationsMOORE KEITH A·Filed 2012·Granted Jul 29, 2014·9 cites·80 claims
- 0882US9060939B2Tranexamic acid formulationsMOORE KEITH A·Filed 2011·Granted Jun 23, 2015·5 cites·34 claims
- 0981US8968777B2Tranexamic acid formulations with reduced adverse effectsHEASLEY RALPH A·Filed 2006·Granted Mar 3, 2015·3 cites·18 claims
- 1072US2009215898A1Tranexamic acid formulationsXANODYNE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1164US2015018419A1Tranexamic acid formulationsMOORE KEITH A·Filed 2014·Application pending·0 cites
- 1261US2009214644A1Tranexamic acid formulations with reduced adverse effectsXANODYNE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1356US2015290157A1Tranexamic acid formulationsFERRING BV·Filed 2015·Application pending·0 cites
- 1450US2005079221A1Ibuprofen narcotic composition and method for making sameFiled 2003·Application pending·0 cites
- 1547US2015290127A1Tranexamic acid formulationsFERRING BV·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John W. Facemire files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →